Epstein-Barr virus (EBV) immediate-early protein
Epstein-Barr virus (EBV) is a human lymphotropic herpesvirus that contributes to the etiology of several lymphoid and epithelial malignancies (reviewed in references 22 and 32).
EBV exists predominantly as a latent episome in B lymphocytes, but it periodically enters a lytic replication cycle to produce progeny viral particles. Lytic cycle reactivation can occur spontaneously or may be induced by various signaling pathways linked to cell stress response and B-cell differentiation (reviewed in reference 4). Lytic cycle replication and associated gene products may contribute directly and indirectly to EBV pathogenesis. In immunosuppressed individuals, increased lytic infection has been directly linked with oral hairy leukoplakia and indirectly linked with risk of non-Hodgkins lymphomas (16, 24) . Detection of lytic antigens correlates with risk of EBV-associated nasopharyngeal carcinoma in areas where the virus is endemic (13) . Recent evidence also indicates that lytic cycle gene products or viral replication is required for EBV-associated tumorigenesis in mouse models (18, 19) . Together, these findings suggest that lytic amplification of infectious virus or viral gene products expressed during latency contribute to EBV-associated pathogenesis.
The EBV lytic cycle can be initiated by ectopic expression of the immediate-early protein Zta (also referred to as BZLF1, ZEBRA, and EB1) (11, 12) . Zta is a member of the basic leucine zipper (B-ZIP) family of DNA binding proteins with sequence similarity to C/EBP, c-jun, and c-fos (23) . Zta binds multiple recognition sites, including AP-1 and C/EBP recognition sites, and activates transcription of both viral and cellular genes (10, 20, 28, 29) . Zta functions as a DNA-bound transcription activator that can recruit cellular general transcription factors and coactivators to target promoters through an amino-terminal activation domain (14) . Zta also functions as a lytic cycle replication factor by recruiting viral replication proteins to the origin of lytic replication (OriLyt) (26, 27, 33) . Zta also modulates cellular functions, including transcription activation of cellular genes encoding transforming growth factor ␤ (10) and fatty acid synthase (25) , inhibition of cell cycle progression (8, 9) , and the disruption of the PML/ND10 (1, 5) . Viruses lacking Zta are incapable of lytic cycle gene expression or DNA replication, indicating that Zta is essential for virus viability (15) .
The Zta B-ZIP domain is essential for the multivalent DNA sequence recognition as well as for mediating interactions with numerous host cell proteins (1, 3, 17, 21, (36) (37) (38) (39) . In addition to recognizing diverse DNA sequences, Zta can recognize cytosine-methylated DNA sequences with higher affinity than unmethylated DNA (7) . Recently, the three-dimensional structure of the Zta B-ZIP domain (amino acids 175 to 245) complexed to DNA was solved by X-ray crystallography (31) . Important new insights were provided from this study, including the discovery of a novel hairpin-like fold in the C-terminal zipper region and a structural explanation for the diverse sequence recognition capability of Zta. However, some of the DNA binding properties of Zta were not apparent in the X-ray structure. For example, S186 plays a key role in the recognition of methylated cytosine (6) , but this residue was mutated to alanine to improve increased resolution of the crystal structure. Similarly, the redox-sensitive cysteine 189 (C189), which we have shown is important for lytic cycle replication (35) and which can affect DNA binding specificity (34) , was mutated to serine (31) in the solved structure. Consequently, the contri-bution of these critical residues to Zta structure and function remain elusive. In the studies presented here, we further explore the role of cysteine residues in Zta function and present evidence that a second cysteine at position 171 (C171) is essential for reactivation and for sequence recognition of C/EBPlike sites. These findings suggest that amino acid residues amino terminal to the consensus B-ZIP domain contribute to sequence recognition by a mechanism not revealed in the crystal structure, but they are nevertheless essential for lytic reactivation.
MATERIALS AND METHODS
Point mutations in Zta were generated by PCR mutagenesis using the Quickchange site-directed mutagenesis kit (Stratagene). Full-length Zta proteins with cysteine substitution mutations were cloned into the BamHI site of a pQE8 bacterial expression vector (QIAGEN). Zta truncation mutations N156 and N166 were cloned into the NheI-HinDIII sites of pET28a. Zta N178 was cloned into the BamHI site of pQE8. Zta wild type (wt), C171S, and C132S were cloned as EcoRI-Sal1 fragments in p3XFLAG-myc-CMV24 vector (Sigma) for mammalian cell expression. Luciferase plasmids for Zp, Rp, Hp, and Mp have been described previously (14) . 3ϫ AP-1/SV-LUC and 3ϫ C/EBP/SV-LUC were generated by cloning the 3ϫ AP-1 oligonucleotide (5ЈGTACCACTGACTCAT CACTGACTCATCACTGACTCATG) or the 3ϫ C/EBP oligonucleotide (5ЈG TACCATTGCGCAATCATTGCGCAATCATTGCGCAATG) into the Asp1/ Nhe1 site of a pGL2 promoter (Invitrogen) which contains the simian virus 40 early promoter region upstream of the luciferase gene. Rta expression vector pRTS15 was a gift from S. D. Hayward and contains the BRLF1 open reading frame in a derivative of pSG5 (Stratagene). All of the methods for this study have been described previously (35) . Sequences of oligonucleotide probes for electrophoretic mobility shift assay (EMSA) have been published previously (31, 35) .
RESULTS AND DISCUSSION
Identification of cysteine residues essential for lytic cycle replication. A series of cysteine-to-serine mutations were introduced into Zta (Fig. 1A) . Previous studies demonstrated that combinations of these cysteines were responsible for redox-sensitive DNA binding but that no single cysteine could completely account for this activity (35) . To further explore the molecular biology of these cysteine residues in mediating Zta functions, we assayed single cysteine-to-serine mutations at positions 189 and 222 as well as combined mutations at positions 189 and 222 (designated 189/222), 132/189/222, 171/189/ 222, and 132/171/189/222. These cysteine substitution mutations were expressed as FLAG-tagged proteins in ZKO-293 cells to determine their ability to stimulate viral reactivation and lytic gene expression. ZKO-293 cells contain a bacmid with the EBV genome lacking the Zta coding sequence, and they are therefore well suited for Zta complementation studies. We found that C189S, C222S, C189/222S, and C132/189/222S ac- These Zta mutants were then tested for their ability to stimulate production of infectious virus ( Fig. 1C ) and amplification of EBV genome DNA (Fig. 1D ). We found the C189S was defective for production of infectious virus and DNA amplification, consistent with our previous report that this cysteine residue was critical for viral lytic cycle replication (35) . We also observed that C171/189/ 222S and C132/171/189/222S were reduced for production of infectious virus (Fig. 1C) and completely defective for amplification of genomic DNA (Fig. 1D ). These findings indicate that combinations of mutations containing C171S were highly defective for transcription activation of some viral early genes and were incapable of lytic cycle DNA replication. Cysteine 171 is required for viral reactivation. To determine if single-serine substitution mutations at C132 or C171 reduced Zta activity, we expressed C132S and C171S in ZKO-293 cells ( Fig. 2A) and assayed by Western blot for activation of early lytic antigens EA-D and Rta. We found that C132S behaved essentially like wild-type Zta, while C171S was defective for activation of EA-D and Rta ( Fig. 2A) . This defect of C171S was further validated by measuring the mRNA levels by reverse transcription-PCR (Fig. 2B) . C171S was incapable of stimulating EA-D or Rta mRNA levels despite identical levels of Zta and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) control mRNA in each reaction. We next tested whether C132S or C171S could stimulate DNA amplification of latently infected EBV in ZKO-293 cells (Fig. 2C) . We found that C132S stimulated viral DNA amplification at a level similar to that of wt Zta (ϳ40-to 50-fold relative to cellular actin DNA), while C171S was incapable of stimulating viral DNA amplification (Fig. 2C) . Both C132S and C171S were expressed to similar levels as wt Zta, as demonstrated by the Western blot shown in Fig. 2A (Zta panel). These findings indicate that C171S is incapable of stimulating viral reactivation of gene expression and lytic replication.
C171 is required for transcription activation of viral early promoters. To further understand the mechanistic basis for the defect in C171S reactivation function, we assayed the ability of C171S and C132S to stimulate transcription activation of four lytic cycle promoters using a luciferase reporter assay (Fig. 3) . We found that C171S was defective for activation of the BMRF1 (Mp), BHLF1 (Hp), BRLF1 (Rp), and BZLF1 (Zp) early region promoters, while C132S behaved indistinguishably from wild-type Zta. In particular, Zta C171S stimulated the Mp and Hp promoters to ϳ14% of wt Zta and stimulated the Rp and Zp promoters to ϳ25-to 30% of the wt. Expression levels for Zta wt, C132S, and C171S were nearly identical, indicating that these differences in transcription activity were not attributable to differences in protein expression levels. These findings indicate that C171S is defective for transcription activation of all of the viral early promoters tested but may also have more pronounced defects at some subset of these promoters.
We next determined whether Zta C171S was defective for binding to the target promoter regions of EBV DNA in vivo using real-time PCR analysis of chromatin-immunoprecipitated (ChIP) DNA (Fig. 4A to D) . We found that C171S was substantially reduced for binding at all promoters tested relative to wt Zta. Binding at BHLF1p and BHRF1p was reduced approximately six-to sevenfold relative to wild-type Zta (Fig.  4A and B) , while binding at BMRF1p and BRLF1p was reduced only approximately twofold relative to wt Zta (Fig. 4C  and D) . These findings suggest that C171S impairs Zta DNA binding capabilities but has more penetrating effects on the DNA binding at some sites (e.g., BHLF1) relative to other sites (BMRF1p).
Since reactivation is strongly dependent on Rta coexpres- sion, and since C171S is defective for transcription activation of Rta through the BRLF1 promoter, we tested whether overexpression of Rta could rescue the C171S defect. Others have found that Rta could rescue the reactivation defects in other Zta mutations, especially the S186A mutation that is defective for binding methylated DNA at the BRLF1 promoter (2). An Rta expression vector was cotransfected with or without Zta wt, C132S, or C171S expression vectors and assayed for Zta, Rta, and EA-D expression (Fig. 4E) , as well as for viral DNA amplification (Fig. 4F ) in ZKO-293 cells. Short exposures of Western blots revealed that EA-D levels were elevated by cotransfection of Rta with Zta wt and Zta C131S but not significantly in the presence of Zta C171S (Fig. 4E, middle  panel) . Longer exposure times indicate that Rta coexpression does stimulate EA-D expression in the presence of C171S but to a lesser extent than that of C131S or wt Zta (Fig. 4E, top  panel) . We also noted that Rta levels were consistently lower in the presence of Zta C171S, suggesting that stabilizing interactions between Zta and Rta may also be affected by mutations in Zta. Expression levels of Zta were nearly identical for wt, C132S, and C171S, as were control levels for cellular PCNA. We next asked whether the addition of Rta was sufficient to rescue the defect in C171S in lytic DNA replication (Fig. 4F) . We found that Rta cotransfection had a slight stimulation on the DNA replication of C132S but had no detectable effect on C171S, which was indistinguishable from vector control, while Zta wt stimulated viral DNA ϳ70-fold. We conclude from these studies that Rta cotransfection cannot rescue the defect of C171S on lytic DNA replication or EA-D transcription activation. These findings indicate that the defect in Zta C171S
is not limited to the expression of Rta through the transcription activation of the BRLF1 promoter.
C171 is required for binding to C/EBP sites but not AP-1 sites. The transcription activation defects at several different promoters (Fig. 3 ) and the failure of Zta C171S to bind BHLF1 and BHRF1 promoter regions by ChIP assay (Fig. 4A  to D) suggest that C171S has a primary defect in DNA binding at some, but not necessarily all, recognition sites. Therefore, we assayed the DNA binding activity of purified Zta proteins for several different Zta recognition sites in vitro using electrophoretic mobility shift assay (EMSA). C171S, C132S, and wt Zta were expressed and purified from Escherichia coli and adjusted to identical protein concentrations (Fig. 5A ). These proteins were assayed for DNA binding to several Zta recognition sequences. We found that C171S bound the BRLF1 ZRE2 site with affinity nearly identical to that of wild-type Zta and C132S (Fig. 5B) . In contrast, Zta C171S was highly defective for binding the more degenerate recognition site ZRE3, also derived from the BRLF1 promoter, relative to Zta wt or C132S (Fig. 5C) . A similar defect in Zta C171S was observed when tested for binding to the cytosine-methylated form of these ZRE3 sites (Fig. 5D) , with no significant change in wt or C132S Zta. These findings suggest that C171S limits the variety of sites recognized by Zta. To further explore this possibility, we compared C171S with wt and C132S Zta for binding to 11-bp probes that contain only the AP-1 or C/EBP recognition sites as described in the crystallographic studies (31) . We found that C171S bound the AP-1 site at levels similar to those of Zta wt and C132S (Fig. 5E) . In striking contrast, C171S was incapable of binding the C/EBP site probe, while the wt and C132S Zta proteins bound with similar affinity to that of the AP-1 site (Fig. 5F ). These findings indicate that C171S abrogates the C/EBP site recognition capability of Zta but has limited effect on the AP-1 binding activity. To determine if this difference in DNA binding recognition correlated with transcription activation function, we generated reporter constructs with either 3ϫ AP-1 sites or 3ϫ C/EBP sites in the pGL2 promoter construct, which places these test sequences immediately upstream of the simian virus early promoter driving the luciferase gene (Fig. 6A) . We compared wt and C171S Zta expression vectors for their ability to stimulate transcription from either 3ϫ AP-1/SV-LUC or 3ϫ C/EBP/SV-LUC in 293 cells. We found that Zta C171S stimulated the AP-1-containing construct to levels ϳ48% of that of wt Zta (Fig. 6B and C) . In contrast, C171S stimulated the C/EBPcontaining construct to only ϳ13% of that of wt Zta (Fig. 6B  and C) . These findings indicate that C171S was approximately threefold more defective for transcription activation of the C/EBP-containing promoter than the AP-1-containing promoter. This activation correlates well with the difference in DNA binding activity (Fig. 5E and F) and further supports our model that C171S affects the DNA recognition capabilities of Zta.
Evidence for a conserved amino-terminal extension of the B-ZIP basic region required for multiple-sequence recognition. A comparison of Zta proteins from the related cercopithecine herpesvirus 15 and callitrichine herpesvirus 3 revealed a strong conservation of the C171 residue as well as an additional stretch of residues extending to amino acid 156 of Zta (Fig. 7A) . To test if this additional stretch of conserved amino acids contribute to DNA binding recognition, we compared Zta proteins with N termini initiating at amino acid 156 (N156), 166 (N166), or 178 (N178) (Fig. 7B) . These proteins were expressed and purified from E. coli and adjusted for protein concentration by Coomassie staining (Fig. 7C) , and they were then assayed for their ability to bind to the AP-1 or C/EBP 11-mer probes (Fig. 7D) . We found that the shortest derivative, N178, bound to AP-1 weakly and did not bind to the C/EBP probe. The N166 truncation bound to the AP-1 probe with high affinity (lanes 5 to 7) but did not bind detectably to the C/EBP probe (lanes 15 to 17). In contrast, the N156 truncation bound with high affinity to AP-1 (lanes 8 to 10) and nearly similar affinity to the C/EBP probe (lanes 18 to 20). These findings indicate that the amino acids N terminal to the canonical basic region of the B-ZIP domain stimulate binding to a C/EBP recognition site. Since the N156 truncation did not bind C/EBP with the same affinity as the AP-1 site but the full-length protein bound both sites with equal affinity (Fig. 5E Conclusions. In this work, we found that serine substitution for cysteine 171 disrupted the transcription activation and lytic cycle replication function of Zta (Fig. 2) . C171S was defective for binding to viral target sequences at several viral promoters in vivo using ChIP assay (Fig. 4A to D) , and purified recombinant C171S was defective for binding to a subset of target sites in vitro (Fig. 5) . C171S in the context of full-length Zta protein bound to AP-1-like sites with nearly equal affinity to wt Zta but did not bind to several non-AP-1 consensus sites or to a consensus C/EBP site. Truncation mutations revealed that amino acids N terminal to the B-ZIP homology domain contribute to the C/EBP site recognition more significantly than to the AP-1 site. X-ray crystallography studies with a Zta truncation protein starting at amino acid 175 showed detectable but reduced binding to C/EBP sites relative to AP-1 sites (31). These structural studies are essentially consistent with our findings, although we now propose that amino acids N terminal to the basic region contribute significantly to multiple-sequence recognition. Additional structural studies with Zta peptides extended in the amino-terminal direction may be informative and may reveal a novel stabilization domain similar to that observed at the C-terminal side of the zipper/dimerization domain.
In addition to these structural implications, our data also indicate that multiple-sequence recognition by Zta is required for lytic cycle reactivation. While we cannot rule out that C171S eliminates some essential protein-protein interactions as well, our data are most consistent with the interpretation that multiple-site recognition properties of Zta are essential for completion of lytic cycle gene expression and DNA replication. Finally, it should be noted that regions amino terminal to other basic homology regions have been described, including the "cap 'n' collar" motif of the MAF family of proteins, which contribute to DNA recognition during the oxidative stress response (30) . We suspect that the region N terminal to the basic homology domain of Zta represents a conserved motif among Zta family members that is essential for multivalent DNA site recognition and other interactions required for lytic cycle activation.
